Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crexendo (CXDO) Gains from Sales and Divestitures (2019 - 2025)

Crexendo's Gains from Sales and Divestitures history spans 7 years, with the latest figure at $228321.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 109.15% year-over-year to $228321.0; the TTM value through Dec 2025 reached $228321.0, up 109.15%, while the annual FY2025 figure was $228321.0, 109.15% up from the prior year.
  • Gains from Sales and Divestitures reached $228321.0 in Q4 2025 per CXDO's latest filing, up from $109166.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $475653.0 in Q4 2022 to a low of $56480.0 in Q4 2021.
  • Average Gains from Sales and Divestitures over 5 years is $253454.2, with a median of $228321.0 recorded in 2025.
  • Peak YoY movement for Gains from Sales and Divestitures: surged 742.16% in 2022, then plummeted 72.55% in 2024.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $56480.0 in 2021, then soared by 742.16% to $475653.0 in 2022, then dropped by 16.4% to $397651.0 in 2023, then tumbled by 72.55% to $109166.0 in 2024, then skyrocketed by 109.15% to $228321.0 in 2025.
  • Per Business Quant, the three most recent readings for CXDO's Gains from Sales and Divestitures are $228321.0 (Q4 2025), $109166.0 (Q4 2024), and $397651.0 (Q4 2023).